Stock Analysis

3 Global Stocks Estimated To Be Undervalued In October 2025

As global markets navigate a mix of volatility and optimism, with U.S. stocks rebounding and central banks signaling further monetary easing, investors are increasingly focused on identifying opportunities amid the shifting economic landscape. In this environment, discerning undervalued stocks can be key to capitalizing on potential market inefficiencies, especially when considering companies that demonstrate resilience despite broader economic uncertainties.

Advertisement

Top 10 Undervalued Stocks Based On Cash Flows

NameCurrent PriceFair Value (Est)Discount (Est)
Tibet GaoZheng Explosive (SZSE:002827)CN¥37.79CN¥74.8449.5%
Pandora (CPSE:PNDORA)DKK883.00DKK1746.0249.4%
Nippon Chemi-Con (TSE:6997)¥1630.00¥3218.0649.3%
Ningxia Building Materials GroupLtd (SHSE:600449)CN¥13.37CN¥26.4549.4%
Lotes (TWSE:3533)NT$1425.00NT$2844.9549.9%
Insource (TSE:6200)¥913.00¥1812.7149.6%
Hanza (OM:HANZA)SEK130.00SEK259.5349.9%
doValue (BIT:DOV)€2.75€5.4949.9%
Aquafil (BIT:ECNL)€1.936€3.8549.7%
Anhui Ronds Science & Technology (SHSE:688768)CN¥47.65CN¥95.2950%

Click here to see the full list of 519 stocks from our Undervalued Global Stocks Based On Cash Flows screener.

Let's dive into some prime choices out of the screener.

CLASSYS (KOSDAQ:A214150)

Overview: CLASSYS Inc. is a global provider of medical aesthetics devices with a market cap of ₩3.06 trillion.

Operations: The company generates revenue from its Surgical & Medical Equipment segment, amounting to ₩294.21 billion.

Estimated Discount To Fair Value: 40.6%

CLASSYS Inc. is trading at a significant discount, approximately 40.6% below its estimated fair value of ₩88,278.75, suggesting potential undervaluation based on cash flows. Recent innovations like the Ultraformer MPT in Canada highlight growth opportunities in non-invasive skin procedures, potentially enhancing revenue streams. Despite a slight decline in quarterly sales and earnings per share compared to last year, the company's projected annual profit growth of 30.6% outpaces market expectations significantly.

KOSDAQ:A214150 Discounted Cash Flow as at Oct 2025
KOSDAQ:A214150 Discounted Cash Flow as at Oct 2025

Zhejiang Cfmoto PowerLtd (SHSE:603129)

Overview: Zhejiang Cfmoto Power Co., Ltd, along with its subsidiaries, is involved in the development, production, marketing, and distribution of motorcycles, off-road vehicles, engines, frames, parts, apparel, and accessories across various global markets including China and other regions such as Asia and North America; the company has a market cap of CN¥36.65 billion.

Operations: Zhejiang Cfmoto Power Co., Ltd generates revenue through its activities in developing, manufacturing, marketing, and delivering motorcycles, off-road vehicles, engines, frames, parts, apparel, and accessories across China and international markets including Asia and North America.

Estimated Discount To Fair Value: 42.4%

Zhejiang Cfmoto Power Ltd. is trading over 20% below its estimated fair value of CNY 421.82, indicating potential undervaluation based on cash flows. The company reported strong financials for the nine months ended September 30, 2025, with net income rising to CNY 1,415.37 million from CNY 1,081.31 million a year ago. Forecasted revenue growth of approximately 20.7% annually surpasses the market average, although earnings growth is slightly below market expectations at around 21.9%.

SHSE:603129 Discounted Cash Flow as at Oct 2025
SHSE:603129 Discounted Cash Flow as at Oct 2025

Shenzhen Capchem Technology (SZSE:300037)

Overview: Shenzhen Capchem Technology Co., Ltd. is engaged in the research, development, production, sale, and servicing of electronic chemicals and functional materials both in China and internationally, with a market cap of CN¥34.81 billion.

Operations: Shenzhen Capchem Technology Co., Ltd. generates revenue through its diverse portfolio of electronic chemicals and functional materials, catering to both domestic and international markets.

Estimated Discount To Fair Value: 29.5%

Shenzhen Capchem Technology is trading over 20% below its fair value estimate of CNY 66.4, reflecting potential undervaluation based on cash flows. The company reported a net income increase to CNY 483.84 million for the half year ended June 30, 2025. Earnings are projected to grow significantly at an annual rate of 26.3%, outpacing the Chinese market average, although revenue growth is expected at a slower pace than earnings growth forecasts suggest.

SZSE:300037 Discounted Cash Flow as at Oct 2025
SZSE:300037 Discounted Cash Flow as at Oct 2025

Turning Ideas Into Actions

Curious About Other Options?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About SZSE:300037

Shenzhen Capchem Technology

Researches and develops, produces, sells, and services electronic chemicals products and functional materials in China and internationally.

Undervalued with excellent balance sheet and pays a dividend.

Advertisement